Site icon Market Globalist

Why BioCryst Pharmaceuticals, Inc. (BCRX) stock is climbing today?

GLYC Stock

GLYC Stock

BioCryst Pharmaceuticals, Inc. (BCRX) announced its first-quarter 2021 financial results after which the BCRX stock happened to be green as its per-share price went up by 8.05% to reach $11.54 a share as of this writing. BCRX stock was gloomy in the previous trading session and dropped by 3.00% at closing.Let’s analyze the financial results to justify the bullish sentiment.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

First Quarter Financial Results:

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free


Balance Sheet& Financial Outlook:

Key Developments:


First-quarter 2021 financial results have made BCRX stock green in the pre-market today.The revenues, as well as the balance sheet of the BCRX stock, increased over the year which is a good sign for the BioCryst stock. Approvals from different marketplaces would prove to be fruitful for BCRX stock. Hence it can be a good bet for investors in the long run.

Get The Best Stocks To Trade Every Day!

Join now to get the pre-market morning brief 100% free

Exit mobile version